TherapeuticsMD, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
TherapeuticsMD, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • TherapeuticsMD, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$1.09M, a 54.8% increase year-over-year.
  • TherapeuticsMD, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$6.09M, a 114% decline year-over-year.
  • TherapeuticsMD, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$10.3M, a 109% decline from 2022.
  • TherapeuticsMD, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $112M.
  • TherapeuticsMD, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$172M, a 6.05% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$6.09M -$1.09M +$1.32M +54.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$7.41M -$734K +$2.87M +79.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-12
Q4 2023 -$10.3M -$883K -$78.6M -101% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $68.3M -$3.38M +$25.6M +88.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $42.7M -$2.41M -$115M -102% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $157M -$3.6M +$45.4M +92.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-12
Q4 2022 $112M $77.7M +$121M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$8.67M -$29M +$18.5M +38.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$27.1M $112M +$155M Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$182M -$49M -$9.64M -24.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$172M -$43M -$873K -2.07% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-23
Q3 2021 -$172M -$47.4M -$14.8M -45.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$157M -$42.7M +$9.32M +17.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$166M -$39.4M +$17.5M +30.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$184M -$42.1M +$7.35M +14.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$191M -$32.6M -$645K -2.02% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-23
Q2 2020 -$190M -$52M +$3.26M +5.9% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-23
Q1 2020 -$193M -$56.8M -$17.3M -43.9% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-23
Q4 2019 -$176M -$49.4M -$10M -25.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$166M -$32M +$3.64M +10.2% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-04
Q2 2019 -$170M -$55.2M -$22M -66.3% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-04
Q1 2019 -$148M -$39.5M -$15.1M -61.9% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-04
Q4 2018 -$133M -$39.4M -$18M -83.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-24
Q3 2018 -$115M -$35.6M -$20.9M -143% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-24
Q2 2018 -$93.7M -$33.2M -$13.5M -68.8% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-24
Q1 2018 -$80.2M -$24.4M -$3.25M -15.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-24
Q4 2017 -$76.9M -$21.4M +$1.41M +6.17% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$78.3M -$14.7M +$10.4M +41.4% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 -$88.7M -$19.7M +$1.42M +6.72% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 -$90.1M -$21.2M -$227K -1.09% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 -$89.9M -$22.8M -$5.35M -30.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-23
Q3 2016 -$84.5M -$25M -$5.54M -28.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-23
Q2 2016 -$79M -$21.1M +$6.13M +22.5% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-23
Q1 2016 -$85.1M -$20.9M -$34K -0.16% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-23
Q4 2015 -$85.1M -$17.5M -$1.18M -7.24% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-28
Q3 2015 -$83.9M -$19.5M -$1.64M -9.2% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-28
Q2 2015 -$82.3M -$27.2M -$16.3M -150% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-28
Q1 2015 -$65.9M -$20.9M -$11.7M -128% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-28
Q4 2014 -$54.2M -$16.3M -$16.3M Oct 1, 2014 Dec 31, 2014 10-K 2016-02-26
Q3 2014 -$37.9M -$17.8M -$17.8M Jul 1, 2014 Sep 30, 2014 10-K 2016-02-26
Q2 2014 -$20.1M -$10.9M -$10.9M Apr 1, 2014 Jun 30, 2014 10-K 2016-02-26
Q1 2014 -$9.21M -$9.18M -$9.18M Jan 1, 2014 Mar 31, 2014 10-K 2016-02-26
Q4 2013 -$28.4K -$8.36K* -$2.63K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 -$25.8K -$7.67K* -$3.42K Jul 1, 2013 Sep 30, 2013 10-K 2015-03-12
Q2 2013 -$22.4K -$6.01K* +$5.84K Apr 1, 2013 Jun 30, 2013 10-K 2015-03-12
Q1 2013 -$28.2K -$6.38K* +$6.91K Jan 1, 2013 Mar 31, 2013 10-K 2015-03-12
Q4 2012 -$35.1K -$5.73K* +$9.58M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 -$9.62M -$4.25K* +$1.48M Jul 1, 2012 Sep 30, 2012 10-K 2015-03-12
Q2 2012 -$11.1M -$11.9K* +$1.05M Apr 1, 2012 Jun 30, 2012 10-K 2015-03-12
Q1 2012 -$12.2M -$13.3K* +$761K Jan 1, 2012 Mar 31, 2012 10-K 2015-03-12
Q4 2011 -$12.9M -$9.59M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-05
Q3 2011 -$1.49M -$1.52M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$1.07M -$797K -296% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$774K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 $30K* Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$269K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.